Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Product sales, net	$ 9,827,444	$ 8,805,906
Cost of products sold	3,034,832	3,905,092
Gross profit	6,792,612	4,900,814
Selling, general and administrative expenses	13,135,796	12,514,323
Research and development expenses	701,378	1,150,209
Depreciation and amortization expense	61,912	63,755
Total operating expenses	13,899,086	13,728,287
Loss from operations	(7,106,474)	(8,827,473)
Interest income (expense)	125,527	54,607
Provision for income Taxes	0	0
Loss before provision for income taxes	(6,980,947)	(8,772,866)
Net loss	(6,980,947)	(8,772,866)
Net loss attributable to noncontrolling interests	(51,843)	(66,735)
Net loss attributable to Milestone Scientific Inc.	$ (6,929,104)	$ (8,706,131)
Net loss per share applicable to common stockholders—
Basic and Diluted (in dollars per share)	$ (0.1)	$ (0.12)
Weighted average shares outstanding and to be issued—
Basic and Diluted (in shares)	72,775,781	70,607,338